Skip to main content
. 2015 Feb 26;112(6):1052–1058. doi: 10.1038/bjc.2015.21

Table 1. The UBC cell line secretome analysis.

Cell line Grade No. of human peptides No. of human proteins No. of EGFR peptides Secretome (EGFR) ngmg−1 Cellular (EGFR) ngmg−1 % Sec
UROtsa NA 5499 763 0 0.40 (0.03), 0.72 (0.08) 43.7 (1.3), 61.4 (3.7) 1.0
MGH-U3 1 10 954 1041 5 4.29 (0.92), 4.46 (1.19) 90.8 (4.7), 94.7 (8.9) 4.7
R-T4 1 8145 1160 1 1.30 (0.36), 2.62 (0.29) 34.0 (18.0), 22.1 (11.8) 9.6
SW-780 1 4181 627 1 2.81 (0.32), 4.11 (0.62) 49.3 (4.50), 62.2 (16.7) 5.9
RT112 2 5900 787 4 0.66 (0.07), 1.18 (0.17) 82.4 (3.3), 62.0 (5.6) 1.3
VM-CUB-1 2 5915 765 16 10.8 (2.39), 9.40 (1.18) 227 (3.79), 151 (41.7) 5.5
5637 2 4188 628 3 0.41 (0.03), 0.68 (0.04) 102 (3.81), 72.8 (0.87) 0.7
T-24 3 7087 916 0 1.19 (0.32), 2.37 (0.57) 27.1 (1.36), 29.0 (3.18) 6.3
HB-CLS-2 3 7135 847 53 252 (92.8), 298 (22.3) 2720 (161), 2646 (927) 10.3

Abbreviations: EGFR=epidermal growth factor receptor; NA=not applicable; % Sec=percentage of secreted EGFR; UBC=urothelial bladder cancer.

The number of unique peptides identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in each secretome and the resulting protein identifications are shown alongside the number of EGFR peptides identified. Proteomic analysis was performed once per cell line. The concentration of EGFR (determined by ELISA on biological triplicates) in paired secretomes and cell lysates is shown as ng EGFR per mg of cellular protein (determined by bicinchoninic acid assay); left value= −PMA, right value= +PMA. The percentage of secreted EGFR (% Sec) is relative to cellular EGFR.